Evidence map›Paper›PMID 35369637›Full record

ArticlePostepy dermatologii i alergologii2022

Acute urticaria in children: course of the disease, features of skin microbiome.

Ekaterina Orlova, Lyudmila Smirnova, Yuri Nesvizhsky, Dmitrii Kosenkov, Elena Zykova

Open access · goldAbstract read
In one paragraph

Article in Postepy dermatologii i alergologii, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. [Systemic treatment of allergies].Dermatologie (Heidelberg, Germany) · 2025
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ekaterina OrlovaDepartment of Dermatology and Venereology, I. M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Lyudmila SmirnovaDepartment of Dermatology and Venereology, I. M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Yuri NesvizhskyDepartment of Dermatology and Venereology, I. M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Dmitrii KosenkovDepartment of Dermatology and Venereology, I. M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Elena ZykovaDepartment of Dermatology and Venereology, I. M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Sechenov University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Quantitative and qualitative changes in the microbiome of the skin affect the emergence and course of allergic diseases, in particular, of acute urticaria. Aim: To investigate the taxonomic composition of the skin microbiota in children with acute urticaria and to study its effect on the course of the disease. Material and methods: In total, 75 children with diagnosed acute urticaria at the age of 7--14 years were examined. The average age of children was 10.83 ±0.95, of which 44 (58.7%) were boys, and 31 (41.3%) were girls. The control group consisted of 30 virtually healthy children of the appropriate age, of whom 16 (53.3%) were boys, and 13 (46.7%) were girls. Results: Regardless of the severity of the disease, the examined children suffering from acute urticaria had sensitization in history with a significant prevalence of food sensitization ( Conclusions: High frequency of

Indexed as

acute urticaria in childrenfeatures of acute urticariasensitization and acute urticariaskin microbiota and urticaria

Identifiers

PMID35369637
PMCPMC8953879
OpenAlexW4214510846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.